Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis

被引：0
|
作者：
Daniel Caldeira
Nilza Gonçalves
Joaquim J. Ferreira
Fausto J. Pinto
João Costa
机构：
[1] Instituto de Medicina Molecular,Clinical Pharmacology Unit
[2] University of Lisbon,Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine
[3] Hospital Garcia de Orta,Cardiology Department
[4] Cardiology Department,Evidence Based Medicine Centre (CEMBE), Faculty of Medicine
[5] CCUL,Portuguese Collaborating Centre of the Cochrane Iberoamerican Network, Faculty of Medicine
[6] CAML,undefined
[7] Faculty of Medicine,undefined
[8] University of Lisbon,undefined
[9] University of Lisbon,undefined
来源：
American Journal of Cardiovascular Drugs | 2015年 / 15卷
关键词：
Atrial Fibrillation; Dabigatran; Venous Thromboembolism; Rivaroxaban; Apixaban;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：259 / 265
页数：6
相关论文
共 50 条
  • [1] Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis
    Caldeira, Daniel
    Goncalves, Nilza
    Ferreira, Joaquim J.
    Pinto, Fausto J.
    Costa, Joao
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (04) : 259 - 265
  • [2] Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
    Caldeira, Daniel
    Costa, Joo
    Ferreira, Joaquim J.
    Lip, Gregory Y. H.
    Pinto, Fausto J.
    CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (07) : 582 - 590
  • [3] Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
    Liu, Fuwei
    Yang, Yunyao
    Cheng, Winglam
    Ma, Jianyong
    Zhu, Wengen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [4] Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
    Daniel Caldeira
    João Costa
    Joaquim J. Ferreira
    Gregory Y. H. Lip
    Fausto J. Pinto
    Clinical Research in Cardiology, 2015, 104 : 582 - 590
  • [5] Non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis
    Zhou, Yunguo
    He, Wenfeng
    Zhou, Yue
    Zhu, Wengen
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (02) : 311 - 317
  • [6] Non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis
    Yunguo Zhou
    Wenfeng He
    Yue Zhou
    Wengen Zhu
    Journal of Thrombosis and Thrombolysis, 2020, 50 : 311 - 317
  • [7] Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis
    Renda, Giulia
    Ricci, Fabrizio
    De Caterina, Raffaele
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (04): : 457 - 461
  • [8] Non-vitamin K antagonist oral anticoagulants in cardioversion of atrial fibrillation: a network meta-analysis
    Kheiri, Babikir
    Haykal, Tarek
    Abdalla, Ahmed
    Osman, Mohammed
    Ahmed, Sahar
    Osman, Khansa
    Bachuwa, Ghassan
    Hassan, Mustafa
    Bhatt, Deepak L.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (02) : 134 - 138
  • [9] Non-vitamin K antagonist oral anticoagulants in cardioversion of atrial fibrillation: a network meta-analysis
    Babikir Kheiri
    Tarek Haykal
    Ahmed Abdalla
    Mohammed Osman
    Sahar Ahmed
    Khansa Osman
    Ghassan Bachuwa
    Mustafa Hassan
    Deepak L. Bhatt
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 134 - 138
  • [10] Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis
    Caldeira, Daniel
    David, Claudio
    Costa, Joao
    Ferreira, Joaquim J.
    Pinto, Fausto J.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (02) : 111 - 118
12345